上半年全球药品销售榜单出炉,在GLP-1(胰高血糖素样肽-1,此类别药品主要用于治疗糖尿病与减重适应证)类药品激战之下,今年的“药王”之争依然充满悬念。2025年8月11日,Insight数据库根据已披露的MNC(跨国药企)财报,正式发布了《2025上半年全球药品销售额TOP50榜单》。数据显示,GLP-1类药物主导市场,前三名均突破百亿美元大关,成为行业增长的核心引擎;另有44款药物销售额突破...
Source Link上半年全球药品销售榜单出炉,在GLP-1(胰高血糖素样肽-1,此类别药品主要用于治疗糖尿病与减重适应证)类药品激战之下,今年的“药王”之争依然充满悬念。2025年8月11日,Insight数据库根据已披露的MNC(跨国药企)财报,正式发布了《2025上半年全球药品销售额TOP50榜单》。数据显示,GLP-1类药物主导市场,前三名均突破百亿美元大关,成为行业增长的核心引擎;另有44款药物销售额突破...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.